Loading compound...
SGLT2 inhibitor
Ipragliflozin is a small molecule drug that works as a sodium/glucose cotransporter 2 (SGLT2) inhibitor. It is primarily studied for the treatment of diabetes mellitus, including type 1 and type 2 diabetes.
How it worksIpragliflozin works by inhibiting the sodium/glucose cotransporter 2, which helps manage blood sugar levels.
Used for
Diabetes mellitusType 1 diabetes mellitusType 2 diabetes mellitus
Conditions
Diabetes mellitusType 1 diabetesType 2 diabetes
Class
SGLT2 inhibitorEndocrine system
How to take
FormsOral
RoutesOral
This drug is currently listed at max phase 4.0 in research contexts provided, but specific clinical dosing instructions were not included in the source data provided for consumer use.
Talk to your doctor
Questions to ask
- ·Is ipragliflozin appropriate for my type of diabetes?
- ·How will ipragliflozin affect my blood sugar levels?
- ·Are there any specific instructions for taking this oral medication?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-25.
